Health Care • Medical/Dental Instruments
$168.65 ▲ +2.26
(+1.36%)
MKT CAP: $4.22B • VOL: 202.5K
52W L $113 52W H $193
ROARABLE / RQD
D+ • 55/100
PIOTROSKI
8 / 9
ICUI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.23B | $2.38B | $2.26B |
| YoY Revenue Growth % | -6.3% | +5.4% | — |
| Gross Profit | $822.0M | $824.8M | — |
| Gross Margin % | 36.8% | 34.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $42.8M | $43.0M | $22.8M |
| Operating Margin % | 1.9% | 1.8% | 1.0% |
| Net Income (GAAP) | $732.0K | -$117.7M | -$29.7M |
| EBITDA (Normalized) | $113.3M | $106.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $179.8M | $204.0M | $166.2M |
| Capital Expenditures (CapEx) | $88.0M | $79.4M | — |
| Free Cash Flow (FCF) | $91.8M | $124.7M | $166.2M |
| FCF Margin % | 4.1% | 5.2% | 7.4% |
| Return on Invested Capital (ROIC %) | 1.0% | 1.0% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.27B | $1.53B | — |
| Total Stockholders' Equity | $2.12B | $1.97B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ICUI.